MSLN and colorectal carcinoma: In cancer, MSLN is overexpressed not only CRC but also in mesothelioma, ovarian cancer, pancreatic cancer, as well as in cervical, endometrial, biliary cancers, uterine serous carcinoma, cholangiocarcinoma, and pediatric acute myeloid leukemia (112, 113).